AR009952A1 - Uso de proteinas como agentes contra las enfermedades autoinmunes. - Google Patents

Uso de proteinas como agentes contra las enfermedades autoinmunes.

Info

Publication number
AR009952A1
AR009952A1 ARP970104244A ARP970104244A AR009952A1 AR 009952 A1 AR009952 A1 AR 009952A1 AR P970104244 A ARP970104244 A AR P970104244A AR P970104244 A ARP970104244 A AR P970104244A AR 009952 A1 AR009952 A1 AR 009952A1
Authority
AR
Argentina
Prior art keywords
autoimmune diseases
proteins
agents against
against autoimmune
arthritis
Prior art date
Application number
ARP970104244A
Other languages
English (en)
Original Assignee
Zetesis Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ITMI961922 external-priority patent/IT1284556B1/it
Priority claimed from ITMI961919 external-priority patent/IT1284553B1/it
Priority claimed from ITMI961921 external-priority patent/IT1284555B1/it
Priority claimed from ITMI961920 external-priority patent/IT1284554B1/it
Application filed by Zetesis Spa filed Critical Zetesis Spa
Publication of AR009952A1 publication Critical patent/AR009952A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/843—Digestive system
    • Y10S530/846—Liver

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Transplantation (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Se describe el uso de proteínas extraídas con ácido perclorico de organos de animales, para la preparacion de medicamentos contra las enfermedadesautoinmunes, en especial con actividad contra la aterosclerosis , artritis, esclerosis multiple,d iabetes.
ARP970104244A 1996-09-18 1997-09-17 Uso de proteinas como agentes contra las enfermedades autoinmunes. AR009952A1 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
ITMI961922 IT1284556B1 (it) 1996-09-18 1996-09-18 Uso di proteine come agenti contro la sclerosi multipla
ITMI961919 IT1284553B1 (it) 1996-09-18 1996-09-18 Uso di proteine come agenti antiartritici
ITMI961921 IT1284555B1 (it) 1996-09-18 1996-09-18 Uso di proteine come agenti antidiabetici
ITMI961920 IT1284554B1 (it) 1996-09-18 1996-09-18 Uso di proteine come agenti antiaterosclerotici

Publications (1)

Publication Number Publication Date
AR009952A1 true AR009952A1 (es) 2000-05-17

Family

ID=27453037

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970104244A AR009952A1 (es) 1996-09-18 1997-09-17 Uso de proteinas como agentes contra las enfermedades autoinmunes.

Country Status (22)

Country Link
US (2) US6468536B1 (es)
EP (1) EP0928197B1 (es)
JP (1) JP2001501925A (es)
KR (1) KR20000036207A (es)
CN (1) CN1151838C (es)
AR (1) AR009952A1 (es)
AT (1) ATE233569T1 (es)
AU (1) AU723669B2 (es)
BR (1) BR9711499A (es)
CA (1) CA2266346A1 (es)
CZ (1) CZ293926B6 (es)
DE (1) DE69719525T2 (es)
DK (1) DK0928197T3 (es)
ES (1) ES2192669T3 (es)
IL (1) IL129024A0 (es)
NO (1) NO991175D0 (es)
NZ (1) NZ334714A (es)
PL (1) PL188746B1 (es)
PT (1) PT928197E (es)
RU (1) RU2196606C2 (es)
TR (1) TR199900596T2 (es)
WO (1) WO1998011909A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7112655B1 (en) 1997-02-27 2006-09-26 Japan Tobacco, Inc. JTT-1 protein and methods of inhibiting lymphocyte activation
JP3521382B2 (ja) 1997-02-27 2004-04-19 日本たばこ産業株式会社 細胞間接着及びシグナル伝達を媒介する細胞表面分子
IT1290828B1 (it) 1997-03-25 1998-12-11 Zetesis Spa Uso di proteine estraibili da organi animali per la preparazione di medicamenti per il trattamento di condizioni patologiche
JP3871503B2 (ja) 1999-08-30 2007-01-24 日本たばこ産業株式会社 免疫性疾患治療剤
JP4210454B2 (ja) 2001-03-27 2009-01-21 日本たばこ産業株式会社 炎症性腸疾患治療剤
JP3597140B2 (ja) 2000-05-18 2004-12-02 日本たばこ産業株式会社 副刺激伝達分子ａｉｌｉｍに対するヒトモノクローナル抗体及びその医薬用途
JP2003535139A (ja) * 2000-06-08 2003-11-25 レイクポール ホールディング ビー．ブイ． 哺乳動物の器官から抽出可能なタンパク質を用いる筋萎縮性側索硬化症の治療方法
JP4212278B2 (ja) 2001-03-01 2009-01-21 日本たばこ産業株式会社 移植片拒絶反応抑制剤
ITMI20010761A1 (it) * 2001-04-10 2002-10-10 Zetesis Spa Uso della proteina uk114 per il trattamento e la prevenzione dell'epatite cronica attiva
ITMI20010762A1 (it) * 2001-04-10 2002-10-10 Zetesis Spa Uso della proteina uk114 o di suoi frammenti per il trattamento e la prevenzione dello shock endotossico
EP1715884B1 (en) * 2004-01-16 2012-03-07 CBIO Limited Chaperonin 10 modulation of toll-like receptor-inducible cytokine and chemokine secretion

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4024247A (en) * 1971-12-27 1977-05-17 Palolab Pharmaceuticals Corporation Composition and method of using a protein mixture derived from liver
IT1244879B (it) * 1990-12-11 1994-09-12 Alberto Bartorelli Estratti da tessuti animali, utili in terapia e in diagnostica.
FR2688227A1 (fr) 1992-03-04 1993-09-10 Inst Nat Sante Rech Med Proteines formant des complexes avec des chaperones et leurs ligands, leurs fragments, leur obtention et leurs applications biologiques.
IT1270618B (it) 1994-07-14 1997-05-07 Zetesis Spa Proteine ad attivita' antitumorale

Also Published As

Publication number Publication date
CZ91599A3 (cs) 1999-08-11
NZ334714A (en) 2000-08-25
US20030108558A1 (en) 2003-06-12
ES2192669T3 (es) 2003-10-16
CN1230892A (zh) 1999-10-06
KR20000036207A (ko) 2000-06-26
DE69719525T2 (de) 2003-10-02
DE69719525D1 (de) 2003-04-10
JP2001501925A (ja) 2001-02-13
PL188746B1 (pl) 2005-04-29
CA2266346A1 (en) 1998-03-26
EP0928197A1 (en) 1999-07-14
AU4774797A (en) 1998-04-14
US6468536B1 (en) 2002-10-22
EP0928197B1 (en) 2003-03-05
AU723669B2 (en) 2000-08-31
NO991175L (no) 1999-03-10
PT928197E (pt) 2003-06-30
RU2196606C2 (ru) 2003-01-20
IL129024A0 (en) 2000-02-17
WO1998011909A1 (en) 1998-03-26
NO991175D0 (no) 1999-03-10
CN1151838C (zh) 2004-06-02
DK0928197T3 (da) 2003-06-23
PL332282A1 (en) 1999-08-30
ATE233569T1 (de) 2003-03-15
CZ293926B6 (cs) 2004-08-18
BR9711499A (pt) 1999-08-24
TR199900596T2 (xx) 1999-06-21

Similar Documents

Publication Publication Date Title
AR009952A1 (es) Uso de proteinas como agentes contra las enfermedades autoinmunes.
PT892638E (pt) Formulacao topica de vitamina d a base de lipossomas
BR0207775A (pt) Lipossomos anfotéricos métodos para carregamento dos mesmos com ingredientes ativos e sua utilização
DK0654078T3 (da) Thrombinblodfraktion til anvendelse i en medicinsk procedure
ES2058411T3 (es) Sustancia fr 901228 y su preparacion.
ES2179273T3 (es) N-bencil-2-fenilindolas como agentes estrogenicos.
PT89534A (pt) Processo para a preparacao de composicoes farmaceuticas anticoagulantes contendo como ingrediente activo proteina c ou proteina c activada combinada com heparina
EA200100458A1 (ru) Антипаразитарные препараты
ES2176487T3 (es) Composiciones cosmeticas y/o farmaceuticas antipruriginosas compuestas de uno o varios anestesicos locales suaves y uno o varios astringentes.
PT929565E (pt) Esteres de nitrato de compostos corticoides e suas aplicacoes farmaceuticas
ES2136725T3 (es) Utilizacion de 2-amino-6-n-propil-amino-4,5,6,7-tetrahidrobenzotiazol (pramipexol) como medicamento con efecto antidepresivo.
AU8439998A (en) Compounds
ATE205401T1 (de) Lokale behandlung von psoriasis unter verwendung neutralisierender antikörper gegen il-8
BR9913515A (pt) Análogo de grf hidrófobo, formulação farmacêutica, uso de análogo de grf, e, processo para o diagnóstico de deficiências de hormÈnio de crescimento em pacientes
DK0800503T3 (da) Hidtil ukendte trien-retinoidforbindelser og fremgangsmåder
ES2080037T1 (es) Medicamento de uso topico con actividad cicatrizante.
BR0010983A (pt) Preparações para a aplicação de agentes antiinflamatórios
AR004093A1 (es) El uso de una proteina derivada de una quimioquina de mamifero y un medicamento util para movilizar celulas tronco hematopoyeticas.
PT734380E (pt) 4-benzoilisoxazois e sua utilizacao como herbicidas
ES2141978T3 (es) Retinoides triciclicos, metodos para su produccion y uso.
AR059965A2 (es) Uso de 8,9-dehidroestrona para la preparacion de un medicamento antioxidante
DE69007374D1 (de) Injektionssystem für die Behandlung von Zellen.
AR021694A1 (es) Retinamidas de acido 7-aril-6-(z)heptatrienoico
ES2066422T3 (es) Expresion de un arn multigenes con actividad de autoempalme.
ES2070298T3 (es) Utilizacion de un desodorante a base de ester de acido undecilenico para la desodorizacion de los lodos de las estaciones de depuracion.

Legal Events

Date Code Title Description
FB Suspension of granting procedure